Bharat Biotech: Providing Covaxin for â,¹150/dose to the govt is not possible in the long run

Written By Zee Media Bureau | Last Updated: Jun 15, 2021, 22:58 PM IST | Source: Zee News

Covaxin, the Coronavirus vaccine, maker Bharat Biotech on Tuesday said the price of Covaxin supplied to the Indian government at ₹150 per dose is a non-competitive price and is not sustainable in the long run and requires a higher price to offset part of the cost.

ZEENEWS TRENDING STORIES

By continuing to use the site, you agree to the use of cookies. You can find out more by Tapping this link